Certificaations & IP
The CL-K1 technology platform is supported by strain deposits, granted patents, international patent filings, and market-specific regulatory documentation. Status is presented by category to distinguish granted rights from pending applications and product-level notifications.
Certifications & Intellectual Property
Regulatory recognition and patent protection supporting CL-K1® and EFILA.
CL-K1® and EFILA are supported by regulatory milestones, product notification records, and intellectual property assets across Korea, Singapore, Malaysia, China, Macau, and international patent pathways.
Certification and regulatory recognition
These milestones reflect the regulatory and market-entry progress of Ceriporia lacerata, CL-K1®, and EFILA-related product applications in key Asian markets.
Ceriporia lacerata recognized as a Health Functional Food Ingredient
Ceriporia lacerata has received recognition in Korea as a health functional food ingredient, supporting its use within regulated functional food development pathways.
CL-K1® recognized as a Food Ingredient / Novel Food Ingredient
CL-K1® has obtained Korean food ingredient recognition, supporting its position as a standardized natural-origin ingredient platform.
EFILA products notified under the HSA Voluntary Notification Scheme
EFILA Blood Sugar Support Jelly and EFILA Advance Blood Sugar Support have been notified under Singapore's HSA voluntary notification scheme.
EFILA Blood Sugar Support Jelly - regulatory progress in Malaysia
EFILA Blood Sugar Support Jelly has obtained Malaysia-related regulatory classification / approval progress as part of its broader market-entry pathway.
Intellectual property portfolio
Patent certificate documents are displayed directly for review, with each certificate paired with its patent title and jurisdiction.
Novel strain of Ceriporia lacerata-K1 and culture composition
Two-stage cultivation composition for metabolic application
Two-stage cultivation composition for liver-related research
Cultured broth of Irpex lacteus mycelium and composition
Irpex lacteus f.k. patent protection in China
Irpex lacteus f.k. patent protection in Macau
PCT international patent pathway
Regulatory status, permitted claims, product classifications, and approved uses may vary by jurisdiction. The information on this page is provided for corporate, scientific, and partnership communication purposes and does not constitute medical advice, treatment claims, or a guarantee of product approval in any market.